Chemical Formula: C12H17N5O5

Chemical Formula C12H17N5O5

Found 29 metabolite its formula value is C12H17N5O5

N2N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.1229632)


CONFIDENCE standard compound; INTERNAL_ID 311 N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   

N2,N2-Dimethylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(dimethylamino)-6,9-dihydro-3H-purin-6-one

C12H17N5O5 (311.1229632)


N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. The mean levels of urinary N2,N2-Dimethylguanosine in the patients with colorectal cancer are significantly higher than those in patients with intestinal villous adenoma or the healthy adults (PMID 15991285). N2,N2-Dimethylguanosine has been identified in the human placenta (PMID: 32033212). N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   

1,7-Dimethylguanosine

2-amino-9-[(2R,3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-oxidooxolan-2-yl]-1,7-dimethyl-6-oxo-6,7-dihydro-1H-9λ⁵-purin-9-ylium

C12H17N5O5 (311.1229632)


1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216) [HMDB] 1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216).

   
   

N2,N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.1229632)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE10

N2,N2-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.1229632)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE20

N2,N2-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.1229632)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE30

N2,N2-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.1229632)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE40

N2,N2-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE0; CorrDec

N,N-Dimethylguanosine; AIF; CE0; CorrDec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE10; CorrDec

N,N-Dimethylguanosine; AIF; CE10; CorrDec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE30; CorrDec

N,N-Dimethylguanosine; AIF; CE30; CorrDec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; LC-tDDA; CE10

N,N-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; LC-tDDA; CE20

N,N-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; LC-tDDA; CE30

N,N-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.1229632)


   

N,N-Dimethylguanosine; LC-tDDA; CE40

N,N-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.1229632)


   

1,7-Dimethylguanosine

1,7-Dimethylguanosine

C12H17N5O5 (311.1229632)


   

Ganciclovir Mono-O-propionate

Ganciclovir Mono-O-propionate

C12H17N5O5 (311.1229632)


   

2-C-methyl-6-O-methyl-guanosine

2-C-methyl-6-O-methyl-guanosine

C12H17N5O5 (311.1229632)


   

N6-(2-Hydroxyethyl)adenosine

N6-(2-Hydroxyethyl)adenosine

C12H17N5O5 (311.1229632)


N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

C12H17N5O5 (311.1229632)


   
   

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

C12H17N5O5 (311.1229632)


   

N(2),N(2)-Dimethylguanosine

N(2),N(2)-Dimethylguanosine

C12H17N5O5 (311.1229632)


A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups.

   
   

2′-O-Methyl-8-methyl guanosine

2′-O-Methyl-8-methyl guanosine

C12H17N5O5 (311.1229632)


2′-O-Methyl-8-methyl guanosine (m8Gm) is a Z-form RNA stabilizer. 2′-O-Methyl-8-methyl guanosine can markedly stabilize the Z-RNA at low salt conditions[1]. m8Gm-contained oligonucleotides stabilize the Z-DNA under low salt conditions[2].